Table 2.
Univariate and multiple linear regression analysis for FFR.
| Univariable analysis | Multivariable analysis 1 | Multivariable analysis 2 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| β | 95% CI | P value | β | 95% CI | P value | β | 95% CI | P value | |
| Age, year | 0.002 | 0.000 to 0.004 | 0.10 | 0 | − 0.001 to 0.003 | 0.43 | 0.001 | − 0.001 to 0.003 | 0.47 |
| Male | − 0.053 | − 0.100 to − 0.005 | 0.03 | 0.023 | − 0.020 to 0.065 | 0.29 | 0.031 | − 0.012 to 0.007 | 0.68 |
| MLD, mm | 0.163 | 0.121 to 0.205 | < 0.001 | 0.165 | 0.124 to 0.206 | < 0.001 | 0.168 | 0.129 to 0.207 | < 0.001 |
| DS, % | 0 | − 0.001 to 0.000 | 0.24 | ||||||
| Lesion length, mm | − 0.001 | − 0.004 to 0.002 | 0.61 | ||||||
| NT-proBNP, pg/ml | 5.3 × 10–6 | 0.000 to 0.000 | 0.68 | ||||||
| cTnI at presentation, ng/l | 0 | − 0.002 to 0.001 | 0.83 | ||||||
| hs-CRP, mg/dl | 0.19 | − 0.019 to 0.058 | 0.33 | ||||||
| Target lesion: LAD | 0.084 | 0.030 to 0.138 | 0.003 | 0.030 | − 0.019 to 0.078 | 0.23 | 0.042 | − 0.004 to 0.089 | 0.077 |
| LV mass index by CT, g/m2 | − 0.001 | − 0.002 to 0.001 | 0.28 | ||||||
| Area at risk mass volume, g | − 0.001 | − 0.002 to 0.000 | 0.026 | 0 | − 0.019 to 0.078 | 0.12 | − 0.001 | − 0.002 to 0.000 | 0.082 |
| Agatston score (Target vessel) | − 2.1 × 10−5 | 0.000 to 0.000 | 0.43 | ||||||
| EF, % | 0.001 | − 0.002 to 0.004 | 0.62 | ||||||
| Mean PCATA | − 0.007 | − 0.010 to − 0.003 | < 0.001 | Not selected | − 0.007 | − 0.010 to − 0.003 | < 0.001 | ||
| Highest PCATA | − 0.007 | − 0.010 to − 0.003 | < 0.001 | Not selected | Not selected | ||||
| Target vessel PCATA | − 0.006 | − 0.009 to − 0.003 | < 0.001 | − 0.005 | − 0.008 to − 0.003 | < 0.001 | Not selected | ||
| CSF at hyperemia, ml/min/g | 0.004 | − 0.015 to 0.023 | 0.67 | ||||||
| Corrected g-CFR | 0.009 | − 0.012 to 0.031 | 0.39 | ||||||